Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Claudia Herrera et al v. Eli Lilly and Company et al
Case Number:
2:13-cv-02702
Court:
Nature of Suit:
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Judge:
Firms
Companies
Sectors & Industries:
-
August 07, 2015
Eli Lilly Defeats Cymbalta Risk Claims In Bellwether Trial
A California federal jury Friday rejected claims by a woman who alleged Eli Lilly & Co. concealed the withdrawal risks of its antidepressant Cymbalta, finding the drugmaker did not mislabel the drug and was not liable for the woman's purported withdrawal symptoms.
-
July 08, 2015
Eli Lilly Fights Plaintiffs' Expert Testimony In Cymbalta Suit
Eli Lilly & Co. told a California federal court Tuesday to exclude testimony by a plaintiffs' expert in two suits over its anti-depressant Cymbalta, arguing that he hasn't backed his conclusions that the drug's warnings on withdrawal risks are insufficient.
-
June 09, 2015
Eli Lilly Pushes To Toss Cymbalta Withdrawal Suits
Eli Lilly & Co. told a California federal court Monday that plaintiffs in two suits accusing the drugmaker of downplaying the alleged withdrawal effects of its antidepressant Cymbalta had not unearthed any new information about the drug's clinical trials that supports their claims.
-
May 01, 2015
Eli Lilly Rips Expert For 'Unreliable' Cymbalta Testimony
Eli Lilly & Co. has argued that a causation expert for the plaintiffs in two lawsuits over its anti-depressant Cymbalta offered "unreliable" testimony at a recent deposition on issues including medical diagnosis for one of the plaintiffs and certain internal company documents.